A standard echocardiographic and tissue Doppler study of morphological and functional findings in children with hypertrophic cardiomyopathy compared to those with left ventricular hypertrophy in the setting of Noonan and LEOPARD syndromes

Cardiology in the Young

Volumn 18, Issue 6, 2008, Pages 575-580

  Cerrato, Fabiana ^a,c   Pacileo, Giuseppe ^a   Limongelli, Giuseppe ^a   Gagliardi, Maria Giulia ^b   Santoro, Giuseppe ^a   Digilio, Maria Cristina ^b   Di Salvo, Giovanni ^a   Ardorisio, Rachele ^b   Miele, Tiziana ^a   Calabrò, Raffaele ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^c NONE   (Italy)

Author keywords

Myocardial hypertrophy; Obstructed ventricular outflow tracts; Syndromes

Indexed keywords

ANGIOCARDIOGRAPHY; ARTICLE; BODY SURFACE; CHILD; CONTROLLED STUDY; CORONARY ARTERY; DEFIBRILLATOR; DIAGNOSTIC ACCURACY; DOPPLER ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY; FEMALE; GENETIC ANALYSIS; HEART LEFT VENTRICLE COMPLIANCE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE RELAXATION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMAGE ANALYSIS; INTERMETHOD COMPARISON; LEOPARD SYNDROME; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE; NOONAN SYNDROME; PREVALENCE;

ADOLESCENT; CARDIOMYOPATHY, HYPERTROPHIC; CHILD; CHILD, PRESCHOOL; CORONARY ANGIOGRAPHY; ECHOCARDIOGRAPHY; FEMALE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; INFANT; ITALY; LEOPARD SYNDROME; MALE; NOONAN SYNDROME; VENTRICULAR OUTFLOW OBSTRUCTION;

EID: 56749173828     PISSN: 10479511     EISSN: 14671107     Source Type: Journal    
DOI: 10.1017/S104795110800320X     Document Type: Article

References (32)

1. Maron BJ, Gottdiener JS, Epstein SE. Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: A wide angle, two-dimensional echocardiographic study of 125 patients. Am J Cardiol 1981; 48: 418-428.
2. Klues HG, Shiffers A, Maron BJ. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: Morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. J Am Coll Cardiol 1995; 26: 1699-1700.
3. Maron B. Hypertrophic cardiomyopathy: A systematic review. JAMA 2002; 287: 1308-1320.
4. Chung MW, Tsoutsman T, Semsariuan C. Hypertrophic cardiomyopathy: From gene defect to clinical disease. Cell Res 2003; 13: 9-20.
5. Bonne G, Carrier L, Richard P, et al. Familial Hypertrophic cardiomyopathy from mutations to functional defects. Circ Res 1998; 83: 580-593.
6. Moolman JC, Corfield VA, Posen B, et al. Sudden death due to troponin T mutations. J Am Coll Cardiol 1997; 29: 549-555.
7. Tartaglia M, Mehler EL, Goldberg R, et al. Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat Genet 2001; 29: 465-468.
8. Pandit B, Sarkozy A, Pennacchio LA, Carta C, et al. Gainof-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy. Nat Genet 2007; 39: 1007-1012.
9. Sarkozy A, Schirinzi A, Lepri F, et al. Clinical lumping and molecular splitting of LEOPARD and NF1/NF1-Noonan syndromes. Am J Med Genet A 2007; 143: 1009-1011.
10. Tartaglia M, Pennacchio LA, Zhao C, et al. Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome. Nat Genet 2007; 39: 75-79.
11. Nagueh SF, Middleton KJ, Kopelen HA, et al. Doppler tissue imaging: A non-invasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 1997; 30: 1527-1533.
12. Nagueh SF, Lakkis NM, Middleton KJ, et al. Doppler estimation of left ventricular filling pressures in patients with hypertrophic cardiomyopathy. Circulation 1999; 99: 254-261.
13. Matsumura Y, Elliott PM, Virdee MS, et al. Left ventricular diastolic function assessed using Doppler tissue imaging in patients with hypertrophic cardiomyopathy: Relation to symptoms and exercise capacity. Heart 2002; 87: 247-251.
14. Rajiv C, Vinereanu D, Fraser AG. Tissue Doppler imaging for the evaluation of patients with hypertrophic cardiomyopathy. Curr Opin Cardiol 2004; 19: 430-436.
15. McMahon CJ, Nagueh SF, Pignatelli RH, et al. Characterization of left ventricular diastolic function by Tissue Doppler Imaging and clinical status in children with hypertrophic cardiomyopathy. Circulation 2004; 109: 1-7.
16. Van der Burgt I, Berends E, Lommen E, et al. Clinical and molecular studies in a large Dutch family with Noonan syndrome. Am J Med Genet 1994; 53: 187-191.
17. Voron DA, Hatfield HH, Kalkhoff RK. Multiple lentigines syndrome. Case report and review of the literarature. Am J Med 1976; 60: 447-456.
18. Digilio MC, Sarkozy A, de Zorzi A, et al. LEOPARD syndrome: Clinical diagnosis in the first year of life. Am J Med Genet A 2006; 140: 740-746.
19. Shapiro LM, McKenna WJ. Distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: A two-dimensional echocardiographic study. J Am Coll Cardiol 1983; 2: 437-444.
20. McKenna WJ, Kleinebenne A, Nihoyannopoulos P, et al. Echocardiographic measurement of right ventricular wall thickness in hypertrophic cardiomyopathy: Relation to clinical and prognostic features. J Am Coll Cardiol 1988; 11: 351-358.
21. Musewe NN, Robertson MA, Benson LN, et al. The dysplastic pulmonary valve: Echocardiographic features and results of balloon dilatation. Br Heart J 1987; 57: 364-370.
22. Houston AB, Sheldon CD, Simpson IA, et al. The severity of pulmonary valve or artery obstruction in children estimated by Doppler ultrasound. Eur Heart J 1985; 6: 786-790.
23. Limongelli G, Pacileo G, Marino B, et al. Prevalence and clinical significance of cardiovascular abnormalities in patients with the LEOPARD syndrome. Am J Cardiol 2007; 100: 736-741.
24. De Zorzi A, Colan SD, Gauvreau K, et al. Coronary artery dimensions may be classified as normal in Kawasaki disease. J Pediatr 1998; 133: 254-258.
25. Henry WL, Ware J, Gardin JM, et al. Echocardiographic measurements in normal subjects. Growth-related changes that occur between infancy and early adulthood. Circulation 1978; 57: 278.
26. Nishikawa T, Ishiyama S, Shimojo T, et al. Hypertrophic cardiomyopathy in Noonan syndrome. Acta Paediatrica Japonica 1996; 38: 91-98.
27. Takahashi K, Kogaki S, Kurotobi S, et al. A novel mutation in the PTPN11 gene in a patient with Noonan syndrome and rapidly progressive hypertrophic cardiomyopathy. Eur J Pediatric 2005; 164: 497-500.
28. Pearl W. Cardiovascular anomalies in Noonan's syndrome. Chest 1977; 71: 677-679.
29. Krams R, Kofflard MJ, Duncker DJ, et al. Decreased coronary flow reserve in hypertrophic cardiomyopathy is related to remodelling of the coronary microcirculation. Circulation 1998; 97: 230-233.
30. Loukas M, Dabrowski M, Kantoch M, et al. A case report of Noonan's syndrome with pulmonary valvar stenosis and coronary aneurysms. Med Sci Monit 2004; 10: CS80-CS83.
31. Burch M, Mann J, Sharland M, et al. Myocardial disarray in Noonan syndrome. Br Heart J 1992; 325: 1753-1760.
32. Ostman-Smith I, Wettrell G, Keeton B, et al. Echocardiographic and electrocardiographic identification of those children with hypertrophic cardiomyopathy who should be considered at high risk of dying suddenly. Cardiol Young 2005; 15: 632-642.